Deep Dives

Google's leap into medical AI applications

July 9, 2023
We summarized this source into key points to remember. To know more about it, please click on the link above.

Receive a daily summary of what happened in tech, powered by ML and AI.

Thank you! We sent you a verification email.
Oops! Something went wrong while submitting the form.
Join 1,500+ thinkers, builders and investors.
Google has developed an artificial intelligence tool called Med-PaLM 2, currently being tested at Mayo Clinic, that is designed to answer healthcare-related questions. Despite exhibiting some accuracy issues, the tool shows promising capabilities in areas such as reasoning and comprehension.

Med-PaLM 2 and Its Purposes: Google's new AI tool, Med-PaLM 2, is being used at Mayo Clinic for testing purposes.
  • It's an adaptation of Google's language model, PaLM 2, that powers Google's Bard.
  • The tool is aimed at helping healthcare in regions with less access to doctors.

  • Training and Performance: Med-PaLM 2 has been trained on a selection of medical expert demonstrations to better handle healthcare conversations.
  • While some accuracy issues persist, as found in a study conducted by Google, the tool performed comparably to actual doctors in aspects such as reasoning and consensus-supported answers.

  • Data Privacy: Users testing Med-PaLM 2 will have control over their data, which will be encrypted and inaccessible to Google.
  • This privacy measure ensures user trust and adherence to data security standards.

  • Tool’s Future and Potential: According to Greg Corrado, Google's senior research director, Med-PaLM 2 is still in its early stages.
  • Despite some hesitation, Corrado believes that Med-PaLM 2 could greatly expand the beneficial applications of AI in healthcare.
  • Further information is anticipated from Google and Mayo Clinic regarding this technology.

  • Did you like this article? 🙌

    Receive a daily summary of the best tech news from 50+ media (The Verge, Tech Crunch...).
    Thank you! We sent you a verification email.
    Oops! Something went wrong while submitting the form.
    Join 1,500+ thinkers, builders and investors.
    You're in! Thanks for subscribing to Techpresso :)
    Oops! Something went wrong while submitting the form.
    Join 5,000+ thinkers, builders and investors.
    Also available on:

    You might also like